Ave. 31 No. 15802 between 158 y 190, Cubanacán, Playa, Havana. C.P. 11600, P.O. Box 6162
webmaster@cigb.edu.cu
(53) 7-2504101; (53) 7-2716022
HOME
ABOUT US
History
Directors
Headquarters
Processes
Research Areas
Events
PRODUCTS
Diagnostic tests
Vaccines
Biopharmaceutical products
Animal Products
Plant Products
Against COVID-19
AGAINST COVID-19
R&D
Biomedical projects
Animal biotechnology projects
Plant biotechnology projects
FAQ
English
Español
English
2021
Home
»
Milestones
2021
Continuation of clinical trials and health interventions with the Abdala vaccine and the Mambisa vaccine candidate against covid-19.
2020
The CIGB contributed 5 drugs, a vaccine and a vaccine candidate that were included in the Cuban protocols against covid-19 pandemic, due to their results.
2019
The Center for Genetic Engineering and Biotechnology (CIGB) obtains the rights to the pharmaceutical company Liof-Pharma in Spain.
2018
The Center for Genetic Engineering and Biotechnology (CIGB) achieves vaccination with Porvac® against the classical swine fever virus, to the entire swine mass of the...
2017
HeberFERON® is being extended to all of Cuba as part of the National Extension Program, and Sanitary registration was granted for Porvac®.
2016
The health registration in Cuba of HeberFERON® is approved and the company Industrial Biotecnológico CIGB - Mariel S.A. was established.
2015
The Center for Genetic Engineering and Biotechnology (CIGB) registers the therapeutic recombinant vaccine HeberNasvac®, for nasal and parenteral administration, against chronic infection by the hepatitis...
2014
Foundation of the Lukang-Heber Mixed Company, between Heber Biotec S.A. and Lukang (China), for agricultural biotechnology products.
2013
The Center for Genetic Engineering and Biotechnology (CIGB) is integrated into the Business Group of Biotechnology and Pharmaceutical Industries, BioCubaFarma, with the aim of producing...
2011
The Heberprot-P® application becomes the Comprehensive Care Program for Diabetic Foot Ulcer Patients and is extended to all municipalities in the country.
2010
The Center for Genetic Engineering and Biotechnology organizes and celebrates the first edition of the International Congress Controlling diabetes and its most severe complications.
2009
The Center for Genetic Engineering and Biotechnology registers the Cuban pentavalent Heberpenta®-L vaccine.
2007
Heberprot-P®, a drug for the treatment of diabetic foot ulcers begins to be used in Cuba.
2003
The Cuban Quimi-Hib® vaccine against Haemophilus influenzae type B was registered and commercialized, the first vaccine achieved by chemical synthesis in the world.
2002
In the television space "University for all", the course "Biotechnology for all" of the Center for Genetic Engineering and Biotechnology was included.
2001
The Center for Genetic Engineering and Biotechnology is selected as a member of the Global Alliance Vaccines and Immunization (GAVI).
2000
The Center for Genetic Engineering and Biotechnology begins to use plants to produce recombinant biopharmaceuticals.
1998
In the Center for Genetic Engineering and Biotechnology, the Directorate of Clinical Trials and Regulatory Affairs was created
1996
The Center for Genetic Engineering and Biotechnology cloned and expressed recombinant human interferon gamma in Escherichia coli.
1995
In the Center for Genetic Engineering and Biotechnology, the Editorial Elfos Scientiae.
1994
The recombinant vaccine Vacoli ™ against porcine colibacillosis is registered in Cuba.
1993
The Center for Genetic Engineering and Biotechnology started the production of the Bm86 antigen for the Gavac® vaccine, an immunogen that acts to control ticks...
1992
The Center for Genetic Engineering and Biotechnology held the first international event Biotechnology Habana'92.
1991
The Center for Genetic Engineering and Biotechnology begins to produce the recombinant surface antigen of the hepatitis B virus for the manufacture of the preventive...
1990
The other headquarters of the Center for Genetic Engineering and Biotechnology is founded in the Cuban province of Sancti Spíritus.
1989
A headquarters of the Center for Genetic Engineering and Biotechnology is founded in the Cuban province of Camagüey, and the First Ibero-American Congress on Biotechnology...
1988
The Center for Genetic Engineering and Biotechnology obtained the first transgenic animal in Cuba (mouse).
1987
1987 At the Center for Genetic Engineering and Biotechnology, the hepatitis B surface antigen (HBsAg) was expressed, the first recombinant protein, obtained in yeast in...
1986
Year of the foundation of the Center for Genetic Engineering and Biotechnology, by Commander-in-Chief Fidel Castro
1985
Cuba held an International Workshop on Genetic Engineering and Biotechnology at the Center for Biological Research.
1984
The first issue of the scientific journal Interferón y Biotecnología was released, which served as a documentary record of the development of research on natural...
1983
Cuba held its First Cuban Seminar on Interferon, established the Cuban Society for Interferon Research, and began the National Program for the treatment of laryngeal...
1982
A few meters from house 149, it was decided to build the Biological Research Center (CIB) to produce interferon.
1980
It all began in November 1980, when a visionary like our Commander in Chief Fidel Castro Ruz, convinced that "the future of our country must...
1981
After Fidel met the famous American specialist Randolph Lee Clark, he began in Cuba the project to obtain interferon to make it accessible to our...